UCB's Global Corporate Website
Welcome to UCB in the United States
  • Healthcare Professionals
  • Patients
  • Investors

    • Categories

    Archives

    Mar

    07

    Innovating and collaborating in immuno-dermatology: a dialogue with UCB’s Simon Lucas & Camille Lee

    Read More Share:linkedin| twitter| email

    Mar

    06

    Putting People First to Create a More Sustainable Healthcare System

    Read More Share:linkedin| twitter| email

    Feb

    22

    Rare Disease Day 2024: The Moment is Now to Be Patient-First to Deliver for People Living with Rare Diseases

    Read More Share:linkedin| twitter| email

    Feb

    12

    Harmony in Health: Partnering for Enhanced Seizure Management and Understanding

    Read More Share:linkedin| twitter| email

    Jan

    11

    Our Wish in 2024: Renewed Hope for People Living with Chronic Inflammatory Diseases

    Read More Share:linkedin| twitter| email

    Dec

    01

    Media Statement on levetiracetam (KEPPRA® and KEPPRA XR®) and DRESS

    Read More Share:linkedin| twitter| email

    Nov

    27

    UCB's Commitment to Diversity, Equity, and Inclusion: Partnering at AES for a Better Future

    Read More Share:linkedin| twitter| email

    Oct

    18

    Evolving Expectations for Dermatological Conditions

    Read More Share:linkedin| twitter| email

    Oct

    17

    Steadfast Towards Our Ambition to Create a UCB Rare Disease Portfolio

    Read More Share:linkedin| twitter| email

    Sep

    12

    Disease Spotlight: Thymidine Kinase 2 Deficiency (TK2d)

    Read More Share:linkedin| twitter| email

    © 2009 - 2020 UCB, Inc., Atlanta. All rights reserved.
    USPR-CORP-0115-00003(2)